GSK plc Form 6-K: Report of foreign private issuer
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2009-12-21: Form 6-K; Period of report 2009-12-21; Description DIRECTOR/PDMR SHAREHOLDING; Document gsk200912216k.htm.
- 2009-12-18: Form 6-K; Period of report 2009-12-18; Description DIRECTOR/PDMR SHAREHOLDING; Document gsk200912186k.htm.
- 2009-12-11: Form 6-K; Period of report 2009-12-11; Description DIRECTOR/PDMR SHAREHOLDING; Document gsk200912116k.htm.
- 2009-12-07: Form 6-K; Period of report 2009-12-07; Description NOTIFIABLE SHARE INTEREST IN ADDEX PHARMACEUTICALS; Document gsk200912076k.htm.
| Filed | Form | Period of report | Description | Document |
|---|---|---|---|---|
| 2009-12-21 | 6-K | 2009-12-21 | DIRECTOR/PDMR SHAREHOLDING | gsk200912216k.htm |
| 2009-12-18 | 6-K | 2009-12-18 | DIRECTOR/PDMR SHAREHOLDING | gsk200912186k.htm |
| 2009-12-11 | 6-K | 2009-12-11 | DIRECTOR/PDMR SHAREHOLDING | gsk200912116k.htm |
| 2009-12-07 | 6-K | 2009-12-07 | NOTIFIABLE SHARE INTEREST IN ADDEX PHARMACEUTICALS | gsk200912076k.htm |
| 2009-12-04 | 6-K | 2009-12-04 | HOLDING(S) IN COMPANY | gsk200912046k.htm |
| 2009-12-01 | 6-K | 2009-12-01 | TOTAL VOTING RIGHTS | gsk200912016k2.htm |
| 2009-12-01 | 6-K | 2009-12-01 | GSK COMPLETES EXTENSION OF STRATEGIC COLLABORATION | gsk200912016k.htm |
| 2009-11-18 | 6-K | 2009-11-18 | BLOCKLISTING INTERIM REVIEW | gsk200911186k.htm |
| 2009-11-12 | 6-K | 2009-11-11 | DIRECTOR/PDMR SHAREHOLDING | gsk200911116k2.htm |
| 2009-11-12 | 6-K | 2009-11-11 | DIRECTOR/PDMR SHAREHOLDING | gsk200911116k.htm |
| 2009-11-09 | 6-K | 2009-11-09 | DIRECTOR/PDMR SHAREHOLDING | gsk200911096k.htm |
| 2009-11-05 | 6-K | 2009-11-05 | DIRECTOR/PDMR SHAREHOLDING | gsk200911056k2.htm |
| 2009-11-05 | 6-K | 2009-11-05 | DIRECTOR/PDMR SHAREHOLDING | gsk200911056k.htm |
| 2009-11-04 | 6-K | 2009-11-04 | DIRECTOR/PDMR SHAREHOLDING | gsk200911046k.htm |
| 2009-11-02 | 6-K | 2009-11-02 | DIRECTOR/PDMR SHAREHOLDING | gsk200911026k3.htm |
| 2009-11-02 | 6-K | 2009-11-02 | TOTAL VOTING RIGHTS | gsk200911026k2.htm |
| 2009-11-02 | 6-K | 2009-11-02 | PHASE 3 TRIAL RESULTS BENLYSTA | gsk200911026k.htm |
| 2009-10-28 | 6-K/A | 2009-10-28 | DIRECTOR/PDMR SHAREHOLDING - AMENDMENT | gsk200910286kamend.htm |
| 2009-10-28 | 6-K | 2009-10-28 | 6-K | u07800e6vk.htm |
| 2009-10-20 | 6-K | 2009-10-20 | DIRECTOR/PDMR SHAREHOLDING | gsk200910206k4.htm |
| 2009-10-20 | 6-K | 2009-10-20 | DIRECTOR/PDMR SHAREHOLDING | gsk200910206k3.htm |
| 2009-10-20 | 6-K | 2009-10-20 | DIRECTOR/PDMR SHAREHOLDING | gsk200910206k2.htm |
| 2009-10-20 | 6-K | 2009-10-20 | DIRECTOR/PDMR SHAREHOLDING | gsk200910206k.htm |
| 2009-10-16 | 6-K | 2009-10-16 | FDA APPROVES CERVARIX | gsk20091016k2.htm |
| 2009-10-16 | 6-K | 2009-10-16 | DIRECTOR/PDMR SHAREHOLDING | gsk200916106k.htm |
| 2009-10-13 | 6-K | 2009-10-12 | DIRECTOR/PDMR SHAREHOLDING | gsk200912106k4.htm |
| 2009-10-13 | 6-K | 2009-10-12 | DIRECTOR/PDMRSHAREHOLDING | gsk200910126k3.htm |
| 2009-10-13 | 6-K | 2009-10-12 | DIRECTOR/PDMR SHAREHOLDING | gsk200912106k2.htm |
| 2009-10-13 | 6-K | 2009-10-12 | DIRECTOR/PDMR SHAREHOLDING | gsk200912106k.htm |
| 2009-10-06 | 6-K | 2009-10-06 | DIRECTOR/PDMR SHAREHOLDING | gsk200910066k3.htm |
| 2009-10-06 | 6-K | 2009-10-06 | GSK EXPANDS PRESENCE IN CHINA VIA JOINT VENTURE | gsk200910066k2.htm |
| 2009-10-06 | 6-K | 2009-10-06 | H1N1 2009 VACCINE UPDATE | gsk200910066k.htm |
| 2009-10-02 | 6-K | 2009-10-02 | DIRECTOR/PDMR SHAREHOLDING | gsk200910026k2.htm |
| 2009-10-02 | 6-K | 2009-10-02 | CHANGES TO BOARD COMMITTEE | gsk200910026k.htm |
| 2009-10-01 | 6-K | 2009-10-01 | TOTAL VOTING RIGHTS | gsk200910016k.htm |
| 2009-09-22 | 6-K | 2009-09-22 | DIRECTOR/PDMR SHAREHOLDING | gsk200909226k.htm |
| 2009-09-18 | 6-K | 2009-09-18 | NOTIFIABLE SHARE INTEREST IN ALGETA ASA | gsk200909186k.htm |
| 2009-09-11 | 6-K | 2009-09-11 | DIRECTOR/PDMR SHAREHOLDING | gsk200909116k.htm |
| 2009-09-01 | 6-K | 2009-09-01 | DIRECTOR/PDMR SHAREHOLDING | gsk200909016k2.htm |
| 2009-09-01 | 6-K | 2009-09-01 | TOTAL VOTING RIGHTS | gsk200909016k.htm |
| 2009-08-21 | 6-K | 2009-08-21 | HOLDING(S) IN COMPANY | gsk200908216k.htm |
| 2009-08-13 | 6-K | 2009-08-13 | DIRECTOR/PDMR SHAREHOLDING | gsk200908136k.htm |
| 2009-08-12 | 6-K | 2009-08-12 | DIRECTOR/PDMR SHAREHOLDING | gsk200908126k.htm |
| 2009-08-11 | 6-K | 2009-08-11 | DIRECTOR/PDMR SHAREHOLDING | gsk200908116k.htm |
| 2009-08-06 | 6-K | 2009-08-06 | DIRECTOR/PDMR SHAREHOLDING | gsk200908066k3.htm |
| 2009-08-06 | 6-K | 2009-08-06 | DIRECTOR/PDMR SHAREHOLDING | gsk200908066k2.htm |
| 2009-08-06 | 6-K | 2009-08-06 | INTEREST IN SHARES IN VERNALIS PLC | gsk200908066k.htm |
| 2009-08-04 | 6-K | 2009-08-04 | GOVERNMENT ORDERS FOR H1N1 VACCINE | gsk200908046k.htm |
| 2009-08-03 | 6-K | 2009-08-03 | DIRECTOR/PDMR SHAREHOLDING | gsk200908036k2.htm |
| 2009-08-03 | 6-K | 2009-08-03 | TOTAL VOTING RIGHTS | gsk200908036k.htm |
| 2009-07-23 | 6-K | 2009-07-23 | DIRECTOR/PDMR SHAREHOLDING | gsk200907236k.htm |
| 2009-07-22 | 6-K | 2009-07-22 | 6-K | u07253e6vk.htm |
| 2009-07-20 | 6-K | 2009-07-20 | DIRECTOR/PDMR SHAREHOLDING | gsk200907206k.htm |
| 2009-07-17 | 6-K | 2009-07-17 | DIRECTOR/PDMR SHAREHOLDING | gsk200907176k.htm |
| 2009-07-15 | 6-K | 2009-07-15 | DIRECTOR/PDMR SHAREHOLDING | gsk200907156k.htm |
| 2009-07-14 | 6-K | 2009-07-14 | DIRECTOR/PDMR SHAREHOLDING | gsk200907146k.htm |
| 2009-07-14 | 6-K | 2009-07-14 | DIRECTOR/PDMR SHAREHOLDING | gsk200907146k2.htm |
| 2009-07-14 | 6-K | 2009-07-14 | DIRECTOR/PDMR SHAREHOLDING | gsk200907146k3.htm |
| 2009-07-10 | 6-K | 2009-07-10 | DIRECTOR/PDMR SHAREHOLDING | gsk200907106k2.htm |
| 2009-07-10 | 6-K | 2009-07-10 | DIRECTOR/PDMR SHAREHOLDING | gsk200907106k3.htm |
| 2009-07-10 | 6-K | 2009-07-10 | CHANGES TO BOARD COMMITTEES | gsk200907106k.htm |
| 2009-07-07 | 6-K | 2009-07-07 | DIRECTOR/PDMR SHAREHOLDING | gsk200907076k.htm |
| 2009-07-02 | 6-K | 2009-07-02 | PORTFOLIO EXTENDED IN MIDDLE EAST AND NORTH AFRICA | gsk200907026k.htm |
| 2009-07-01 | 6-K | 2009-07-01 | DIRECTOR/PDMR SHAREHOLDING | gsk200907016k2.htm |
| 2009-07-01 | 6-K | 2009-07-01 | TOTAL VOTING RIGHTS | gsk200907016k.htm |
| 2009-06-11 | 6-K | 2009-06-11 | DIRECTOR/PDMRSHAREHOLDING | gsk200906116k.htm |
| 2009-06-10 | 6-K | 2009-06-10 | DIRECTOR/PDMR SHAREHOLDING | gsk200906106k.htm |
| 2009-06-09 | 6-K | 2009-06-09 | NEPTUNUS JOINT VENTURE | gsk200906096k.htm |
| 2009-06-02 | 6-K | 2009-06-02 | DIRECTOR/PDMR SHAREHOLDING | gsk200906026k.htm |
| 2009-06-01 | 6-K | 2009-06-01 | TOTAL VOTING RIGHTS | gsk200906016k.htm |
| 2009-05-29 | 6-K | 2009-05-29 | DIRECTOR/PDMR SHAREHOLDING | gsk200905296k.htm |
| 2009-05-21 | 6-K | 2009-05-21 | AGM - SPECIAL BUSINESS | gsk200905216k.htm |
| 2009-05-20 | 6-K | 2009-05-20 | RESULT OF AGM | gsk200905206k.htm |
| 2009-05-20 | 6-K | 2009-05-19 | DIRECTOR/PDMR SHAREHOLDING | gsk200905196k.htm |
| 2009-05-15 | 6-K | 2009-05-15 | DIRECTOR/PDMR SHAREHOLDING | gsk200905156k2.htm |
| 2009-05-15 | 6-K | 2009-05-15 | A (H1N1) INFLUENZA VACCINE | gsk200905156k.htm |
| 2009-05-13 | 6-K | 2009-05-13 | DIRECTOR/PDMR SHAREHOLDING | gsk200905136k.htm |
| 2009-05-12 | 6-K | 2009-05-12 | GSK EXTENDS STRATEGIC COLLABORATION WITH ASPEN | gsk200905126k.htm |
| 2009-05-11 | 6-K | 2009-05-11 | DIRECTOR/PDMR SHAREHOLDING | gsk200905116k5.htm |
| 2009-05-11 | 6-K | 2009-05-11 | DIRECTOR/PDMR SHAREHOLDING | gsk200905116k4.htm |
| 2009-05-11 | 6-K | 2009-05-11 | DIRECTOR/PDMR SHAREHOLDING | gsk200905116k3.htm |
| 2009-05-11 | 6-K | 2009-05-11 | DIRECTOR/PDMR SHAREHOLDING | gsk200905116k2.htm |
| 2009-05-11 | 6-K | 2009-05-11 | BLOCKLISTING INTERIM REVIEW | gsk200905116k.htm |
| 2009-05-08 | 6-K | 2009-05-08 | DIRECTOR/PDMR SHAREHOLDING | gsk200905086k.htm |
| 2009-05-06 | 6-K | 2009-05-06 | WELLBUTRIN XL US DIVESTITURE | gsk200905066k.htm |
| 2009-05-05 | 6-K | 2009-05-05 | DIRECTOR/PDMR SHAREHOLDING | gsk200905056k.htm |
| 2009-05-01 | 6-K | 2009-05-01 | TOTAL VOTING RIGHTS | gsk200905016k.htm |
| 2009-04-27 | 6-K | 2009-04-27 | REDUCE TOPLINE RESULTS | gsk200904276k.htm |
| 2009-04-22 | 6-K | 2009-04-22 | 6-K | u06749e6vk.htm |
| 2009-04-20 | 6-K | 2009-04-20 | GSK TO ACQUIRE STIEFEL LABORATORIES INC | gsk200904206k.htm |
| 2009-04-16 | 6-K | 2009-04-16 | DIRECTOR/PDMR SHAREHOLDING | gsk200904166k3.htm |
| 2009-04-16 | 6-K | 2009-04-16 | DIRECTOR/PDMR SHAREHOLDING | gsk200904166k2.htm |
| 2009-04-16 | 6-K | 2009-04-16 | GSK SPECIALIST HIV COMPANY | gsk200904166k.htm |
| 2009-04-14 | 6-K | 2009-04-14 | DIRECTOR/PDMR SHAREHOLDING | gsk200904146k.htm |
| 2009-04-14 | 6-K | 2009-04-14 | DIRECTOR/PDMR SHAREHOLDING | gsk200904146k2.htm |
| 2009-04-07 | 6-K | 2009-04-07 | DIRECTOR/PDMR SHAREHOLDING | gsk200904076k.htm |
| 2009-04-06 | 6-K | 2009-04-06 | TOTAL VOTING RIGHTS | gsk200904066k.htm |
| 2009-04-01 | 6-K | 2009-04-01 | DIRECTOR/PDMR SHAREHOLDING | gsk200904016k.htm |
| 2009-03-30 | 6-K | 2009-03-30 | U.S. FDA FILING-CERVARIX | gsk200903306k.htm |
| 2009-03-27 | 6-K | 2009-03-27 | ANNUAL INFORMATION UPDATE | gsk200903276k2.htm |